Improving Vitiligo Outcomes for Patients With Skin of Color
The burden of vitiligo is significant in patients with skin of color, which makes treatment breakthroughs more impactful. Dr. Pearl E. Grimes, chair of the Pigmentary Disorders Exchange Symposium, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about breakthroughs in the treatment of vitiligo in patients with skin of color. Find out which therapies have enhanced results i …
The burden of vitiligo is significant in patients with skin of color, which makes treatment breakthroughs more impactful. Dr. Pearl E. Grimes, chair of the Pigmentary Disorders Exchange Symposium, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about breakthroughs in the treatment of vitiligo in patients with skin of color. Find out which therapies have enhanced results i … Continue reading "Improving Vitiligo Outcomes for Patients With Skin of Color"
Hair loss can carry significant psychosocial consequences, especially when hair is significant to a person’s spirituality and community. Among head-covering women, alopecia may lead to substantial emotional distress. Many also delay or avoid dermatologic evaluation because clinical encounters can feel exposing or disrespectful. As a result, head-covering women with hair loss are frequently under … 
Women's Health/AOL and Marie Claire have recently written articles on oils and juices to treat hair loss. Moringa oil is lauded for its ability to nourish the scalp and protect against hair breakage. Rosemary oil is noted for its ability to increase blood flow to the scalp, while fans of onion juice say it improves scalp health. Is there any value to adding these oils and juices to a hair loss … 
Post-inflammatory hyperpigmentation and hypopigmentation can be tricky to treat. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Pooja Sodha, associate professor of dermatology at GW School of Medicine & Health Sciences. Watch as Dr. Sodha outlines her strategies for treating post-inflammatory hyperpigmentation (PIH) and hypopigmentation. Learn why it� … 
Psoriasis is one of the most common immune-mediated inflammatory dermatoses, with increasing evidence for systemic comorbidities. Targeted systemic agents have revolutionized the management of moderate-to-severe psoriasis, with life-changing outcomes for many patients with the chronic disease. Injectable biologics, blocking interleukin (IL)-23 or IL-17 cytokine pathways, have become invaluable opt …